Avastin(reg) Is First Medicine To Extend Survival Beyond One Year In Patients With Previously Untreated Non-small Cell Lung Cancer

... Avastin(reg) is the first medicine proven to help previously untreated patients suffering from the most common form of lung cancer to live longer than a year, according to a landmark US study (E4599) published in the prestigious New England Journal of Medicine.The study showed that the median duration of survival in the Avastin plus paclitaxel and carboplatin chemotherapy group was 12. [click link for full article] ...